Search
Search Results
##search.searchResults.foundPlural##
-
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3625PDF: 1540HTML: 4442CoverLetter: 191Figure1: 204 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1234PDF: 611HTML: 6806 -
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
3092PDF: 1041HTML: 427TABLE: 199FIGURES: 266 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1209PDF: 847HTML: 2190Figue 1: 182 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2221PDF: 1631HTML: 321 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2004PDF: 832HTML: 2208Table 1: 190Table 2: 207Table 3: 203Table 4: 206Table 5: 203Tble 6: 196Cover Letter: 214Greene Tab.7: 206 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3808PDF: 1615HTML: 564Figures . Eliassian: 233 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3627PDF: 2549HTML: 1525 -
-
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1820PDF: 1187HTML: 258 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3426PDF: 1503HTML: 4017 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1673PDF: 604HTML: 238 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1243PDF: 937HTML: 293 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2525PDF: 1332HTML: 1803CoverLetter: 189 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
2160PDF: 1560HTML: 536 -
-
-
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4891PDF: 2895HTML: 2320 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2922PDF: 974HTML: 7354 -
-
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4922PDF: 1334HTML: 1922Untitled: 190Untitled: 186 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2044PDF: 97HTML: 27 -
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2335PDF: 1347HTML: 17104Bassan Fig.1: 153Bassan Fig.2: 168Bassan Fig.4: 145Fig.3: 213 -







